Chargement en cours...
Driving toward targeted therapy for LCH
In this issue of Blood, Brown et al identify somatic mutations of MAP2K1 capable of driving the RAS-RAF-MEK-ERK pathway in Langerhans cell histiocytosis (LCH). Their findings lend important insight into the pathogenesis of this disease and provide the rationale for exploring targeted approaches in c...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4155264/ https://ncbi.nlm.nih.gov/pubmed/25190750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-07-587378 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|